Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06547788

LEFT ATRIAL MONITORING IN PATIENTS BEFORE AND AFTER MITRAL SURGERY - LAMBDA STUDY

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Ottawa Heart Institute Research Corporation · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Mitral valve leakage, or mitral regurgitation (MR), is associated with heart failure symptoms including shortness of breath, fatigue, irregular heart rate. When left untreated, it may cause death. Patients with MR can be divided in two broad groups: those with primary MR, caused by disease of the mitral valve structures, and those with secondary MR, due to dilation of the heart chambers. Our study focuses on patients with primary MR. The standard treatment for severe symptomatic primary MR is mitral valve surgery, a type of open-heart surgery. The outcomes following this procedure are excellent, however, a subset of patients continue to experience heart failure symptoms after surgery due to very high pressures in the heart, more specifically in the left atrium, which is one of the four heart chambers. This is called functional mitral stenosis (FMS). Previous studies have shown that creating a small opening between the left and right atria can help relieve the pressure inside the left atrium. We would like to determine whether creating this opening between the two atria at the time of mitral valve surgery can help prevent FMS. To answer this question, we will study two groups of patients who need mitral valve surgery for primary MR. The first group will undergo mitral valve surgery, along with the creation of the opening between the two atria. The second group will undergo mitral valve surgery alone. We will then compare the outcomes between both groups, namely with regards to their heart failure symptoms after open-heart surgery.

Conditions

Interventions

TypeNameDescription
OTHERMitral valve repair with creation of an 8 mm inter-atrial shuntMitral valve repair with creation of an 8 mm inter-atrial shunt

Timeline

Start date
2024-09-30
Primary completion
2028-01-31
Completion
2030-01-31
First posted
2024-08-09
Last updated
2024-08-09

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06547788. Inclusion in this directory is not an endorsement.